Lidocaine topical patch - Kaken Pharmaceutical
Alternative Names: KN 48Latest Information Update: 20 Jan 2022
At a glance
- Originator Kaken Pharmaceutical
- Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Non-opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor agonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Neuralgia
Most Recent Events
- 14 Jul 2004 Phase-II clinical trials in postherpetic neuralgia in Japan (unspecified route)